NEW YORK (GenomeWeb News) – Thermo Fisher Scientific plans to offer its 2.5 percent senior convertible notes in an effort to raise funding to refinance some of its outstanding debts, the company said today.

The life sciences and biotech firm intends to offer the 2.5 percent senior notes, due 2023, of which $295.4 million aggregate principal amount is outstanding as of November 12, 2009, in a private placement to qualified institutional investors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.